产品编号：O237127
产品规格：25mg
产品价格：面议
| 标准品编号: | O237127 |
| 名称: | Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24 |
| 别名: | 2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-Hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontane-γ-cyclodextrin-d24 Derivative; 6A,6B,6C,6D,6E,6F,6G,6H-Octabromo-6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-γ-cyclodextrin; 6-Bromo-6-deoxy-γ-cyclodextrin-d24; 6-Bromo-6-deoxy-γ-cyclodextrin-d24 |
| 参考CAS号: | 类似: 53784-84-2 |
| 分子式: | C₄₈H₄₈D₂₄Br₈O₃₂ |
| 外观: | Off-white to Brown Solid |
| 分子量: | 1824.45 |
| 溶解度: | DMF; DMSO |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin-d24 is an intermediate in synthesizing Sugammadex Sodium-deuterated (S698102), which is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits. |
| 参考文献 | |
